Ads
    Related paper
  1. CORRECTION OF THE NON-ALCOHOLIC STEATOHEPATITIS MANIFESTATIONS IN THE PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY
  2. Possibilities of correction of lipid-phospholipid disorders in patients with non-alcoholic steatohepatitis against obesity and pathology of the biliary tract
  3. Peculiarities of the Blood Lipid Spectrum Correction in Patients with Non-Alcoholic Steatohepatitis and Comorbid Hypertension of II Stage
  4. Diagnostics of progression of liver fibrosis in patients with non-alcoholic steatohepatitis combined with obesity and chronic calculous cholecystitis
  5. Clinical characteristics of patients with hepatic steatosis and non-alcoholic steatohepatitis combined with obesity and disorders of the biliary tract, depending on the body mass index
  6. FEATURE OF THE CLINICAL MANIFESTATIONS IN PATIENTS WITH DISORDERS OF URIC ACID METABOLISM IN COMBINATION WITH OBESITY 58 AND NON-ALCOHOLIC STEATOHEPATATIS
  7. CORRECTION OF RESISTANT ARTERIAL HYPERTENSION IN PATIENTS WITH CHRONICKIDNEYDISEASE STAGE I–III
  8. CHANGES IN IMMUNOLOGICAL INDICATORS IN PATIENTS WITH CHRONIC PERIODONTITIS WITH ARTERIAL HYPERTENSION AND OBESITY
  9. THE MANIFESTATIONS OF UNDIFFERENTIATED CONNECTIVE TISSUE DYSPLASIA ON THE PART OF THE CARDIOVASCULAR SYSTEM IN PATIENTS WITH ARTERIAL HYPERTENSION
  10. Evaluation of Metabolic Disorders in Patients with Arterial Hypertension in Combination with Obesity on Nesfatin-1 Level